Ning Zu

Efficacy and safety of once weekly semaglutide 2·4 mg for weight management in a predominantly east Asian population with overweight or obesity (STEP 7): a double-blind, multicentre, randomised controlled trial

Yiming Mu, Xiao-lei Bao, Freddy G. Eliaschewitz et al. · The Lancet Diabetes & Endocrinology · 2024 · 97 citations

Obesity, Medicine, Clinical Trials +9

Efficacy and safety of once‐weekly semaglutide versus once‐daily sitagliptin as add‐on to metformin in patients with type 2 diabetes in <scp>SUSTAIN China</scp> : A 30‐week, double‐blind, phase 3a, randomized trial

Linong Ji, Xiaolin Dong, Yiming Li et al. · Diabetes Obesity and Metabolism · 2020 · 92 citations · Full text

Left Ventricular Diastolic Dysfunction — Early Cardiac Impairment in Patients with Polymyositis/Dermatomyositis: A Tissue Doppler Imaging Study

Lu Zhang, Wei Qiao, Ning Zu et al. · The Journal of Rheumatology · 2013 · 36 citations · Full text

Clinical significance of peripheral blood lymphocyte subsets in patients with polymyositis and dermatomyositis

Dong Xue Wang, Xin Lu, Ning Zu et al. · Clinical Rheumatology · 2012 · 35 citations

Rheumatology, Immunohematology, Autoimmune Disease +12

Therapeutic Mechanism of Saikosaponin-d in Anti-Thy1 mAb 1-22-3-Induced Rat Model of Glomerulonephritis

Ping Li, Yuewen Gong, Ning Zu et al. · Nephron Experimental Nephrology · 2005 · 32 citations